DURECT Corp Files Q1 2025 10-Q

Durect Corp 10-Q Filing Summary
FieldDetail
CompanyDurect Corp
Form Type10-Q
Filed DateMay 14, 2025
Risk Levelmedium
Sentimentneutral

Sentiment: neutral

Topics: 10-Q, financials, pharmaceuticals

Related Tickers: DRRX

TL;DR

DURECT Corp Q1 25 10-Q filed. Financials and stock info updated.

AI Summary

DURECT Corp filed its 10-Q for the period ending March 31, 2025. The filing details financial performance and operational updates, including information related to its ALZET product line and various stock and warrant activities. The company's address is 10240 Bubb Road, Cupertino, CA.

Why It Matters

This filing provides investors with a quarterly update on DURECT Corp's financial health and strategic direction, crucial for investment decisions.

Risk Assessment

Risk Level: medium — The filing contains information about stock and warrant valuations, which can be complex and subject to market volatility.

Key Numbers

  • 20250331 — Period End Date (Financial reporting period)
  • 20250514 — Filing Date (Date the report was submitted)

Key Players & Entities

  • DURECT CORP (company) — Filer
  • 20250331 (date) — Period of Report
  • 10240 BUBB ROAD (address) — Business Address
  • CUPERTINO (city) — Business Address City
  • CA (state) — Business Address State
  • 95014 (zip_code) — Business Address Zip
  • ALZET (product) — Product Line

FAQ

What is the reporting period for this 10-Q filing?

The Conformed Period of Report is 20250331, meaning the filing covers the quarter ending March 31, 2025.

Where is DURECT Corp located?

DURECT Corp's business address is 10240 Bubb Road, Cupertino, CA 95014.

What product line is specifically mentioned in the filing data?

The ALZET product line is mentioned in the filing data.

What is the SEC file number for DURECT Corp?

The SEC File Number for DURECT Corp is 000-31615.

When was the filing submitted?

The filing was submitted on 20250514.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on May 14, 2025 regarding DURECT CORP.

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.